Abiopharma

Clinical trial NCT06816108 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 60 → 35 participants 3. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT00911560 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2027-05-01 → 2026-08-03 3. primary completion date: 2027-05-01 → 2026-08-03

Clinical trial NCT07153146 updates: 1. status: RECRUITING → COMPLETED 2. completion date: 2026-06-15 → 2026-07-29 3. primary completion date: 2026-06-15 → 2026-07-29 4. enrollment: 142 → 146 participants 5. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06203210 updates: 1. completion date: 2029-02-22 → 2029-12-01 2. primary completion date: 2027-04-30 → 2028-01-30

Clinical trial NCT07619443 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. start date: 2026-07-06 → 2026-07-01

Clinical trial NCT05701800 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2026-06-30 → 2025-12-31 3. primary completion date: 2026-06-30 → 2025-12-31

Clinical trial NCT06238466 updates: 1. completion date: 2026-08-31 → 2027-04-08 2. enrollment: 96 → 98 participants

Clinical trial NCT07560111: status: NOT_YET_RECRUITING → RECRUITING.

Clinical trial NCT07193199 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-06-24 → 2026-07-24 3. enrollment type: ESTIMATED → ACTUAL

Kemper Announces Inducement Equity Awards for Newly Hired Executive

Stryker declares an $0.88 per share quarterly dividend

Corpay Cross-Border Named the Official FX Partner of Ultimate Sevens

Texas Benefits From 13,000 New Kinetic Fiber Builds

Oklahoma Benefits From 8,000 New Kinetic Fiber Builds

Kentucky Benefits From 14,000 New Kinetic Fiber Builds